OptiBiotix Health Plc (LSE:OPTI) — Market Cap & Net Worth
Market Cap & Net Worth: OptiBiotix Health Plc (OPTI)
OptiBiotix Health Plc (LSE:OPTI) has a market capitalization of $74.78K (GBX614.64 Million) as of June 20, 2026. Listed on the LSE stock exchange, this UK-based company holds position #31357 globally and #1163 in its home market, demonstrating a -6.30% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying OptiBiotix Health Plc's stock price GBX5.95 by its total outstanding shares 103300304 (103.30 Million). Review OptiBiotix Health Plc (OPTI) financial obligations to assess the company's total debt and financial obligations.
OptiBiotix Health Plc Market Cap History: 2015 to 2026
OptiBiotix Health Plc's market capitalization history from 2015 to 2026. Data shows change from $1.12 Million to $74.78K (-18.71% CAGR).
Index Memberships
OptiBiotix Health Plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$939.61 Million | 0.01% | #389 of 722 |
Weight: OptiBiotix Health Plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
OptiBiotix Health Plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how OptiBiotix Health Plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.26x
OptiBiotix Health Plc's market cap is 0.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $1.12 Million | $28.20K | -$1.28 Million | 39.89x | N/A |
| 2016 | $766.69K | $288.12K | -$1.30 Million | 2.66x | N/A |
| 2017 | $810.68K | $191.07K | $1.91 Million | 4.24x | 0.43x |
| 2018 | $1.14 Million | $514.29K | -$1.92 Million | 2.22x | N/A |
| 2019 | $829.53K | $744.88K | -$2.37 Million | 1.11x | N/A |
| 2020 | $728.98K | $1.52 Million | $5.80 Million | 0.48x | 0.13x |
| 2021 | $578.16K | $2.21 Million | $6.26 Million | 0.26x | 0.09x |
| 2022 | $166.53K | $457.00K | $2.59 Million | 0.36x | 0.06x |
| 2023 | $336.21K | $644.00K | -$2.04 Million | 0.52x | N/A |
| 2024 | $226.24K | $870.00K | -$1.80 Million | 0.26x | N/A |
Competitor Companies of OPTI by Market Capitalization
Companies near OptiBiotix Health Plc in the global market cap rankings as of June 20, 2026.
Key companies related to OptiBiotix Health Plc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #221 globally with a market cap of $110.45 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #445 globally with a market cap of $62.84 Billion USD.
- UCB SA (BR:UCB): Ranked #547 globally with a market cap of $49.68 Billion USD ( €42.50 Billion EUR).
- Argen-X (BR:ARGX): Ranked #573 globally with a market cap of $47.14 Billion USD ( €40.32 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #221 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $110.45 Billion | $451.63 |
| #445 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $62.84 Billion | $609.94 |
| #547 | UCB SA | BR:UCB | $49.68 Billion | €249.20 |
| #573 | Argen-X | BR:ARGX | $47.14 Billion | €762.80 |
OptiBiotix Health Plc Historical Marketcap From 2015 to 2026
Between 2015 and today, OptiBiotix Health Plc's market cap moved from $1.12 Million to $ 74.78K, with a yearly change of -18.71%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX74.78K | -11.85% |
| 2025 | GBX84.84K | -62.50% |
| 2024 | GBX226.24K | -32.71% |
| 2023 | GBX336.21K | +101.89% |
| 2022 | GBX166.53K | -71.20% |
| 2021 | GBX578.16K | -20.69% |
| 2020 | GBX728.98K | -12.12% |
| 2019 | GBX829.53K | -27.47% |
| 2018 | GBX1.14 Million | +41.09% |
| 2017 | GBX810.68K | +5.74% |
| 2016 | GBX766.69K | -31.84% |
| 2015 | GBX1.12 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 19th, 2026 the market cap of OptiBiotix Health Plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $74.78K USD |
| MoneyControl | $74.78K USD |
| MarketWatch | $74.78K USD |
| marketcap.company | $74.78K USD |
| Reuters | $74.78K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About OptiBiotix Health Plc
OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulation products in the United Kingdom, the United States, India, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential… Read more